Australia markets closed

Ocular Therapeutix Inc (0OT.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
8.78+0.58 (+7.02%)
At close: 08:15PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
61,097
58,443
51,494
43,522
17,403
Cost of revenue
5,599
5,281
4,540
4,406
2,083
Gross profit
55,498
53,162
46,954
39,116
15,320
Operating expenses
Research development
80,805
61,055
53,462
50,083
28,694
Selling general and administrative
89,163
74,489
72,146
67,070
49,473
Total operating expenses
169,968
135,544
125,608
117,153
78,167
Operating income or loss
-114,470
-82,382
-78,654
-78,037
-62,847
Interest expense
14,825
11,338
7,022
6,671
6,768
Total other income/expenses net
-21,695
9,001
13,840
78,122
-86,189
Income before tax
-138,361
-80,736
-71,038
-6,553
-155,636
Income from continuing operations
-138,361
-80,736
-71,038
-6,553
-155,636
Net income
-138,361
-80,736
-71,038
-6,553
-155,636
Net income available to common shareholders
-138,361
-80,736
-71,038
-6,553
-155,636
Basic EPS
-0.92
-1.01
-0.92
-0.09
-2.56
Diluted EPS
-0.97
-1.02
-0.97
-0.98
-2.56
Basic average shares
76,875
79,827
76,875
76,393
60,752
Diluted average shares
82,644
85,597
82,644
82,162
60,752